Skip to main content

Table 3 Differences in breastfeeding and non-breastfeeding in mothers with SLE six weeks after delivery

From: Breastfeeding in women with systemic lupus erythematosus: results from a Norwegian quality register

 

N

Breastfeeding

N = 87

N

Non-breastfeeding

N = 24

p-value a

Age, mean (SD)

86

31.5 (4.2)

24

32.9 (5.4)

0.18

 Age ≥ 35 yrs (%)

 

20.9

 

45.8

0.02

BMI kg/m2 mean (SD)

75

24.2 (4.8)

21

25.5(6.0)

0.43

 Overweight (> 25 kg/m) (%)

 

42.9

 

36.4

0.63

Disease duration yrs (SD)

 

7.5 (5.4)

 

7.2 (6.0)

0.67

Duration of pregnancy (weeks)

85

38.0

24

37.1

0.26

Birth before gestational week 37 n (%)

85

15 (17.6)

24

7 (29.2)

0.25

Birth weight (grams) mean (SD)

86

3133 (650)

24

2869 (974)

0.42

C- section total %

86

14

24

29.2

0.12

Emergency c-section (%)

 

5.8

 

20.8

0.04

Preeclampsia (%)

84

7.1

24

21.7

0.06

VAS scores (0–100 mm) median (IQR)

 Pain

65

10 (2–22)

17

10 (5–21)

0.67

 Fatigue

65

31 (8–56)

17

41 (17–50)

0.74

 Global score

65

15 (3–35)

17

22 (7–45)

0.35

CRP mg/L mean (SD)

77

2.3 (5.6)

24

3.4 (4.3)

0.13

Inflammatory active diseaseb (%)

71

10.0

20

15.0

0.69

Regular physical activityc (%)

47

48.9

19

42.1

0.79

Educational levels (%)

83

 

23

 

0.05

 Low

 

3.6

 

13.0

 

 Middle

 

20.5

 

26.1

 

 High

 

75.9

 

60.9

 

Working status (full or part-time) (%)

86

 

24

  

Medications, n (%)

87

 

24

  

 HCQ

 

64 (73.6)

 

19 (79.2)

0.79

 sDMARDsd

 

28 (32.2)

 

7 (29.2)

1.00

 bDMARDse

 

0

 

1 (4.2)

-

  1. BMI body mass index, CRP C-reactive protein, VAS visual analog scale, IQR interquartile range, c-section caesarean section, HCQ hydroxychloroquine, sDMARDs synthetic disease modifying anti-rheumatic drugs, bDMARDs biologic disease modifying anti-rheumatic drugs, Educational levels: low = elementary school, medium = high school/vocational education, high = college/university
  2. agroup comparisons were performed using Fisher´s exact test for categorical variables and independent samples t-test for continuous, normally distributed variables. For ordinal and continuous, non-normally distributed data Mann Whitney U test was performed
  3. bmeasured by LAI-P/SLEDAI. Active disease: ≥ 2,2 (LAI-P) or > 6 (SLEDAI)
  4. cat least once weekly
  5. dsDMARDs included azathioprine, methotrexate, sulphasalazine and mycophenolate mofetil
  6. ebDMARDs included belimumab, TNF-inhibitors and interleukin inhibitors